These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 443343

  • 1. Comparison of therapeutic routes in experimental Pseudomonas keratitis.
    Davis SD, Sarff LD, Hyndiuk RA.
    Am J Ophthalmol; 1979 May; 87(5):710-6. PubMed ID: 443343
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs.
    Davis SD, Sarff LD, Hyndiuk RA.
    Arch Ophthalmol; 1977 Sep; 95(9):1638-43. PubMed ID: 197908
    [Abstract] [Full Text] [Related]

  • 3. Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy.
    Davis SD, Sarff LD, Hyndiuk RA.
    Arch Ophthalmol; 1978 Jan; 96(1):126-8. PubMed ID: 414703
    [Abstract] [Full Text] [Related]

  • 4. Relative efficacy of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis.
    Davis SD, Sarff LD, Hyndiuk RA.
    Can J Ophthalmol; 1980 Jan; 15(1):28-9. PubMed ID: 6769572
    [Abstract] [Full Text] [Related]

  • 5. Experimental Pseudomonas keratitis in guinea-pigs: therapy of moderately severe infections.
    Davis SD, Sarff LD, Hyndiuk RA.
    Br J Ophthalmol; 1979 Jun; 63(6):436-9. PubMed ID: 465416
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Studies of tobramycin eye drops. Report 3. Therapeutic effect in experimental Peudomonas keratitis (author's transl)].
    Oishi M, Nishizuka K, Motoyama M, Ogawa T.
    Nippon Ganka Gakkai Zasshi; 1977 Nov 10; 81(11):1783-6. PubMed ID: 613826
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'Callaghan RJ.
    Curr Eye Res; 1995 Mar 10; 14(3):229-34. PubMed ID: 7796606
    [Abstract] [Full Text] [Related]

  • 10. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
    Rootman DS, Hobden JA, Jantzen JA, Gonzalez JR, O'Callaghan RJ, Hill JM.
    Arch Ophthalmol; 1988 Feb 10; 106(2):262-5. PubMed ID: 3124801
    [Abstract] [Full Text] [Related]

  • 11. Nebcin in the treatment of experimental Pseudomonas keratitis.
    Belfort R, Smolin G, Okumoto M, Kim HB.
    Br J Ophthalmol; 1975 Dec 10; 59(12):725-9. PubMed ID: 814918
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of Pseudomonas aeruginosa keratitis with tobramycin and gentamicin: animal experiments (author's transl)].
    Behrens-Baumann W, Paul HH, Ansorg R.
    Klin Monbl Augenheilkd; 1981 Mar 10; 178(3):197-9. PubMed ID: 7230715
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effect of topical antibiotic on untreated eye in experimental keratitis.
    Davis SD, Sarff LD, Hyndiuk RA.
    Can J Ophthalmol; 1978 Oct 10; 13(4):273-6. PubMed ID: 105787
    [Abstract] [Full Text] [Related]

  • 14. [Intraocular penetration and effect of tobramycin in experimental Pseudomonas keratitis (author's transl)].
    Oishi M, Nishizuka K, Motoyama M, Ogawa T.
    Nippon Ganka Gakkai Zasshi; 1975 Sep 10; 79(9):1329-35. PubMed ID: 1239949
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P, Riske PS, Zaya NE, Carey R, Bouchard CS.
    J Ocul Pharmacol Ther; 2007 Jun 10; 23(3):213-20. PubMed ID: 17593004
    [Abstract] [Full Text] [Related]

  • 16. Experimental keratitis due to Pseudomonas aeruginosa: model for evaluation of antimicrobial drugs.
    Davis SD, Chandler JW.
    Antimicrob Agents Chemother; 1975 Sep 10; 8(3):350-5. PubMed ID: 810084
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
    McCormick C, Caballero A, Tang A, Balzli C, Song J, O'Callaghan R.
    Curr Med Res Opin; 2008 Jun 10; 24(6):1569-75. PubMed ID: 18423106
    [Abstract] [Full Text] [Related]

  • 18. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
    Gritz DC, McDonnell PJ, Lee TY, Tang-Liu D, Hubbard BB, Gwon A.
    Cornea; 1992 Mar 10; 11(2):143-7. PubMed ID: 1582217
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic administration in bacterial keratitis.
    Davis SD, Sarff LD, Hyndiuk RA.
    Arch Ophthalmol; 1982 Jun 10; 100(6):1010-1. PubMed ID: 7092628
    [No Abstract] [Full Text] [Related]

  • 20. Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
    Assil KK, Frucht-Perry J, Ziegler E, Schanzlin DJ, Schneiderman T, Weinreb RN.
    Invest Ophthalmol Vis Sci; 1991 Dec 10; 32(13):3216-20. PubMed ID: 1748553
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.